[11C]glyburide PET imaging for quantitative determination of the importance of Organic Anion-Transporting Polypeptide transporter function in the human liver and whole-body

被引:5
作者
Marie, Solene [1 ,2 ,3 ]
Breuil, Louise [1 ]
Chalampalakis, Zacharias [1 ]
Becquemont, Laurent [4 ,6 ]
Verstuyft, Celine [5 ,6 ]
Lecoq, Anne-Lise [4 ]
Caille, Fabien [1 ]
Gervais, Philippe [1 ]
Lebon, Vincent [1 ]
Comtat, Claude [1 ]
Bottlaender, Michel [1 ]
Tournier, Nicolas [1 ]
机构
[1] Univ Paris Saclay, Serv Hosp Freder Joliot, CEA, Inserm,CNRS,BioMaps, 4 Pl Gen Leclerc, F-91401 Orsay, France
[2] Univ Paris Saclay, Dept Pharm Clin, Fac Pharm, F-92296 Chatenay Malabry, France
[3] Univ Paris Saclay, Hop Bicetre, AP HP, Pharm Clin, F-94270 Le Kremlin Bicetre, France
[4] Univ Paris Saclay, Hop Bicetre, AP HP, Ctr Rech Clin, F-94270 Le Kremlin Bicetre, France
[5] Univ Paris Saclay, Hop Bicetre, AP HP, Serv Genet Mol Pharmacogenet & Hormonol, F-94270 Le Kremlin Bicetre, France
[6] Univ Paris Saclay, Fac Med, MOODS Team, CESP,INSERM,UMR 1018, F-94275 Le Kremlin Bicetre, France
关键词
C-11]glyburide; Hepatocyte; Liver; PET; Pharmacokinetics; Positron emission tomography Transporters; CANCER RESISTANCE PROTEIN; 22 ANTITUBERCULOSIS DRUGS; GLYBURIDE; PHARMACOKINETICS; BRAIN; DISPOSITION; GLIBENCLAMIDE; DELIVERY;
D O I
10.1016/j.biopha.2022.113994
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Organic Anion-Transporting Polypeptides (OATPs) are known to control the liver uptake of many drugs. Nonhepatic expression of OATPs has been reported although functional importance for whole-body pharmacokinetics (WBPK) remains unknown. Glyburide is a well described substrate of several hepatic and non-hepatic OATPs. Dynamic whole-body positron emission tomography (DWB-PET) with [11C]glyburide was performed in humans for determination of the importance of OATPs for liver uptake and WBPK. Seven healthy male subjects (24.7 +/- 3.2 years) underwent [11C]glyburide PET scan with concomitant blood sampling. All subjects underwent baseline [11C]glyburide PET scan. Five subjects underwent a subsequent [11C]glyburide PET scan after infusion of the potent OATP inhibitor rifampicin (9 mg/kg i.v.). The transfer constant (kuptake) of [11C]glyburide from blood to the liver was estimated using the integration plot method. The tissue exposure of [11C]glyburide was described by the area under the time-activity curve (AUC) and corresponding tissue/blood ratio (AUCR). [11C] glyburide was barely metabolized in both the baseline and rifampicin conditions. Parent (unmetabolized) [11C] glyburide accounted for > 90 % of the plasma radioactivity. Excellent correlation was found between radioactive counting in arterial blood samples and in the image-derived input function, in both the baseline and rifampicin conditions (R2 = 97.9 %, p < 0.01). [11C]glyburide predominantly accumulated in the liver. Rifampicin decreased liver kuptake by 77.3 +/- 7.3 %, which increased exposure in blood, kidneys, spleen, myocardium and brain (p < 0.05). No significant change in AUCR was observed except in the liver (p < 0.01). [11C]glyburide benefits from metabolic stability and high sensitivity to OATP inhibition which enables quantitative determi-nation of OATP function. DWB-PET suggests negligible role for non-hepatic OATPs in controlling the tissue distribution of [11C]glyburide.
引用
收藏
页数:8
相关论文
共 56 条
  • [1] Impact of rifampicin-inhibitable transport on the liver distribution and tissue kinetics of erlotinib assessed with PET imaging in rats
    Amor, Dorra
    Goutal, Sebastien
    Marie, Solene
    Caille, Fabien
    Bauer, Martin
    Langer, Oliver
    Auvity, Sylvain
    Tournier, Nicolas
    [J]. EJNMMI RESEARCH, 2018, 8
  • [2] Focused ultrasound for opening blood-brain barrier and drug delivery monitored with positron emission tomography
    Arif, Wejdan M.
    Elsinga, Philip H.
    Gasca-Salas, Carmen
    Versluis, Michel
    Martinez-Fernandez, Raul
    Dierckx, Rudi A. J. O.
    Borra, Ronald J. H.
    Luurtsema, Gert
    [J]. JOURNAL OF CONTROLLED RELEASE, 2020, 324 (324) : 303 - 316
  • [3] Influence of OATPs on Hepatic Disposition of Erlotinib Measured With Positron Emission Tomography
    Bauer, Martin
    Matsuda, Akihiro
    Wulkersdorfer, Beatrix
    Philippe, Cecile
    Traxl, Alexander
    Ozvegy-Laczka, Csilla
    Stanek, Johann
    Nics, Lukas
    Klebermass, Eva-Maria
    Poschner, Stefan
    Jaeger, Walter
    Patik, Izabel
    Bakos, Eva
    Szakacs, Gergely
    Wadsak, Wolfgang
    Hacker, Marcus
    Zeitlinger, Markus
    Langer, Oliver
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 104 (01) : 139 - 147
  • [4] Positron Emission Tomography Imaging of [11C]Rosuvastatin Hepatic Concentrations and Hepatobiliary Transport in Humans in the Absence and Presence of Cyclosporin A
    Billington, Sarah
    Shoner, Steven
    Lee, Scott
    Clark-Snustad, Kindra
    Pennington, Matthew
    Lewis, David
    Muzi, Mark
    Rene, Shirley
    Lee, Jean
    Tot Bui Nguyen
    Kumar, Vineet
    Ishida, Kazuya
    Chen, Laigo
    Chu, Xiaoyan
    Lai, Yurong
    Salphati, Laurent
    Hop, Cornelis E. C. A.
    Xiao, Guangqing
    Liao, Mingxiang
    Unadkat, Jashvant D.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 106 (05) : 1056 - 1066
  • [5] Phase 0/microdosing approaches: time for mainstream application in drug development?
    Burt, Tal
    Young, Graeme
    Lee, Wooin
    Kusuhara, Hiroyuki
    Langer, Oliver
    Rowland, Malcolm
    Sugiyama, Yuichi
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2020, 19 (11) : 801 - 818
  • [6] Automated two-step manufacturing of [11C]glyburide radiopharmaceutical for PET imaging in humans
    Caille, Fabien
    Gervais, Philippe
    Auvity, Sylvain
    Coulon, Christine
    Marie, Solene
    Tournier, Nicolas
    Kuhnast, Bertrand
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 2020, 84-85 : 20 - 27
  • [7] Total-Body PET: Maximizing Sensitivity to Create New Opportunities for Clinical Research and Patient Care
    Cherry, Simon R.
    Jones, Terry
    Karp, Joel S.
    Qi, Jinyi
    Moses, William W.
    Badawi, Ramsey D.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (01) : 3 - 12
  • [8] Transplacental Pharmacokinetics of Glyburide, Rhodamine 123, and BODIPY FL Prazosin: Effect of Drug Efflux Transporters and Lipid Solubility
    Cygalova, Lenka Hahnova
    Hofman, Jakub
    Ceckova, Martina
    Staud, Frantisek
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 331 (03) : 1118 - 1125
  • [9] Impact of kidney dysfunction on hepatic and intestinal drug transporters
    Drozdzik, Marek
    Oswald, Stefan
    Drozdzik, Agnieszka
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2021, 143
  • [10] Dose-response assessment of cerebral P-glycoprotein inhibition in vivo with [18F]MC225 and PET
    Garcia-Varela, Lara
    Mossel, Pascalle
    Aguiar, Pablo
    Vazquez-Matias, Daniel A.
    van Waarde, Aren
    Willemsen, Antoon T. M.
    Bartels, Anna L.
    Colabufo, Nicola A.
    Dierckx, Rudi A. J. O.
    Elsinga, Philip H.
    Luurtsema, Gert
    [J]. JOURNAL OF CONTROLLED RELEASE, 2022, 347 : 500 - 507